Hexacosanoic Acid-d4 |
| Catalog No.GC45469 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1208837-79-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Hexacosanoic acid-d4 is intended for use as an internal standard for the quantification of hexacosanoic acid by GC- or LC-MS. Hexacosanoic acid is a 26-carbon saturated (26:0) very-long-chain fatty acid. Plasma levels of hexacosanoic acid are increased in a mouse model of adrenoleukodystrophy, a peroxisomal disorder.1 Increased levels of hexacosanoic acid in red blood cells or in plasma positively correlated with atherosclerotic risk factors and metabolic syndrome, respectively.2,3
References
1. Kobayashi, T., Shinnoh, N., Kondo, A., et al. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232(3), 631-636 (1997).
2. Antoku, Y., Tsukamoto, K., Miyoshi, Y., et al. Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. Atherosclerosis 153(1), 169-173 (2000).
3. Kume, A., Miyazaki, T., Kitamura, Y., et al. High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men. Diab. Res. Clin. Pract. 80(2), 259-264 (2008).
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *